Join the 200th Anniversary Celebration

Original Article

Brief Report

Genetic Analysis of a Sarcoma Accidentally Transplanted from a Patient to a Surgeon

Hermine-Valeria Gärtner, M.D., Christian Seidl, M.D., Christine Luckenbach, Ph.D., Georg Schumm, M.D., Erhard Seifried, M.D., Horst Ritter, M.D., and Burkhard Bültmann, M.D.

N Engl J Med 1996; 335:1494-1497November 14, 1996

Article

Modern concepts of cancer immunology originated from the classic observations by Jensen, Loeb, Tyzzer, and Little in the early years of the 20th century of the rejection of transplanted allogeneic tumors and the acceptance of syngeneic tumors.1 Despite this law of transplantation, there are several clinical examples of the accidental transplantation of a malignant tumor or tumor cells into a healthy recipient.2-5

We describe the accidental transplantation of a malignant sarcoma from a patient to a surgeon. Using molecular methods, we showed that the sarcomas in the unrelated patient and surgeon were genetically identical.

Case Report

A 32-year-old man underwent emergency surgery to remove a malignant fibrous histiocytoma from his abdomen and died shortly thereafter of postoperative complications. During the operation the 53-year-old surgeon injured the palm of his left hand while placing a drain. The lesion was immediately disinfected and dressed. Five months later, the surgeon consulted a hand specialist because of a hard, circumscribed, tumor-like swelling, 3.0 cm (1.2 in.) in diameter, in his left palm at the base of the middle finger, where he had been injured during the operation. An extensive examination, including laboratory tests, did not reveal any signs of immune deficiency. The tumor was completely excised. Histologic examination revealed that it was a malignant fibrous histiocytoma. Two years later, the surgeon's condition was good, and there was no evidence of recurrence or metastasis of the tumor.

The pathologist who investigated both the patient's tumor and the surgeon's tumor raised the question whether the tumors were identical.

Methods

Histologic and Immunohistologic Analysis

Samples of tumor tissue from the patient and surgeon were embedded in paraffin and stained with hematoxylin and eosin, periodic acid–Schiff, and van Gieson's stain. Immunostaining was performed with the avidin–biotin–peroxidase method, with antibodies against vimentin, lysozyme, alpha1-antitrypsin, alpha1-antichymotrypsin, keratin, endomysial antigens, S100, actin, and desmin (all antibodies were obtained from Dako, Glestrup, Denmark).

Isolation of DNA

Genomic DNA from peripheral-blood samples was isolated by the “salting-out” method.6 DNA from paraffin-embedded tumor and tissue samples was extracted according to a modification7 of the method of Goelz et al.8

Analysis of Short Tandem-Repeat Polymorphisms

Short tandem-repeat polymorphisms of the loci HUMTH01, HUMCYAR04, and HUMACTBP2 were amplified by the polymerase chain reaction (PCR) with fluorescence-labeled primers. Primer sequences were chosen from published sequences.9-11 The 5' primer for HUMCYAR04 was labeled with 5-carboxylfluorescein, whereas the 5' primers for HUMTH01 and HUMACTBP2 were labeled with 6-carboxy-2',4',7',4,7-hexachlorofluorescein. PCR products were analyzed with an automated DNA sequencer (model 373A, Applied Biosystem Division, Perkin-Elmer, Foster City, Calif.).

Sequence-Based Typing of HLA Genes

Typing of HLA-DRB1 and DQB1 alleles was performed by allele-specific PCR amplification in combination with solid-phase direct DNA sequencing. Sequence analysis was performed on an automated DNA sequencer (model 373A, Perkin-Elmer). Primer sequences were chosen from genomic sequences of HLA-DRB1 and DQB1 12 or from published sequences.13

Results

Histologic analysis of tumor tissues from the surgeon and the patient revealed that they were morphologically identical. Both tumors were malignant fibrous histiocytomas of the storiform–pleomorphic subtype (Figure 1AFigure 1Histologic Findings (Panels A and B) and Immunologic Findings (Panel C) on Analysis of the Patient's and the Surgeon's Tumors.). They consisted mainly of fibroblast-like and histiocyte-like cells, arranged in a fascicular and storiform pattern, intermingled with some pleomorphic cells and a few inflammatory cells. There were numerous mitotic figures and many necrotic areas. In the periphery of the surgeon's tumor, there was intense inflammation, with an infiltrate consisting mainly of lymphocytes and macrophages and few plasma cells (Figure 1B). Both tumors stained for vimentin, alpha1-antitrypsin, and alpha1-antichymotrypsin.

Analysis of short tandem-repeat sequences clearly demonstrated a chimeric constellation of alleles in the surgeon's tumor (Figure 1C). Allele 11 (187 bp) of HUMCYAR04, allele 8 (166 bp) of HUMTH01, and allele 31 (300 bp) of HUMACTBP2 were detected in the tumors from both the patient and the surgeon (Table 1Table 1Results of Analysis of Polymorphic Short Tandem-Repeat Sequences and HLA Analysis.). To rule out a tumor-specific genetic pattern of these short tandem-repeat polymorphisms, a DNA sample from another malignant fibrous histiocytoma, histologically identical to the tumors of the patient and the surgeon, was analyzed. The allelic profile of this control malignant fibrous histiocytoma, identified by analysis of short tandem-repeat sequences, was clearly distinct from that of the patient's and the surgeon's tumors (Table 1).

Sequence analysis of HLA-DRB1 and DQB1 genes revealed a constellation of heterozygous alleles in the patient's tumor and in the peripheral blood of the surgeon (Table 1). All four alleles, two from the patient's tumor and two from the surgeon's blood cells, were present in the tumor sample from the surgeon.

Discussion

We used histologic and immunohistologic methods, analysis of short tandem-repeat polymorphisms, and sequence-based typing of HLA genes to determine the genetic origin of a sarcoma that had been accidentally transplanted from a patient to a surgeon. Both the pattern of short tandem-repeat sequences and the chimeric constellation of HLA alleles in the surgeon's tumor identified the genetic origin of the sarcoma. The patient and the surgeon had different HLA haplotypes, with complete discrepancies of DRB1 and DQB1 alleles. The patient died before we could perform HLA class I typing, but from the linkage disequilibrium between HLA genes we can assume that there were also major class I mismatches between the patient and the surgeon.

Normally, transplantation of allogeneic tissue from one person to another induces an immune response that leads to the rejection of the transplanted tissue.1,14-17 In the case of the surgeon, an intense inflammatory reaction developed in the tissue surrounding the tumor, but the tumor mass increased, suggesting an ineffective antitumor immune response. The tumor may have escaped immunologic destruction through several mechanisms, such as qualitative and quantitative changes of major histocompatibility complex class I molecules on the tumor cells, an absence of immunogenic tumor antigens,18-22 deficient antigen processing by the tumor, or deficient presentation of tumor antigens by the host's antigen-presenting cells in the absence of costimulatory signals with consequent T-cell and B-cell anergy.23-25

We are indebted to Dr. Hans Georg Rammensee for his critical review of the manuscript and to Utz Bacher for his excellent secretarial assistance.

Source Information

From the Institutes of Pathology (H.-V.G., B.B.) and Anthropology and Human Genetics (C.L., H.R.), Eberhard-Karls-Universität, Tübingen; the Institute of Transfusion Medicine and Immunohematology, Red Cross Blood Donor Service, Frankfurt am Main (C.S., E.S.); and the Institute of Pathology, General Hospital, Heilbronn (G.S.) — all in Germany.

Address reprint requests to Dr. Gärtner at the Institute of Pathology, Eberhard-Karls-Universität, Liebermeisterstraße 8, D-72076 Tübingen, Germany.

References

References

  1. 1

    Klein J. Natural history of the major histocompatibility complex. New York: John Wiley, 1986.

  2. 2

    Southam CM. Homotransplantation of human cell lines. Bull N Y Acad Med 1958;34:416-423
    Medline

  3. 3

    Nadler SH, Moore GE. Immunotherapy of malignant disease. Arch Surg 1969;99:376-381
    Web of Science | Medline

  4. 4

    Scanlon EF, Hawkins RA, Fox WW, Smith WS. Fatal homotransplanted melanoma: a case report. Cancer 1965;18:782-789
    CrossRef | Web of Science | Medline

  5. 5

    Gugel EA, Sanders ME. Needle-stick transmission of human colonic adenocarcinoma. N Engl J Med 1986;315:1487-1487
    Full Text | Web of Science | Medline

  6. 6

    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215-1218
    CrossRef | Web of Science | Medline

  7. 7

    Luckenbach C, Gartner HV, Seidl C, Ritter H. Tumor inoculation between two unrelated human individuals: STR analysis of paraffin-embedded tissue section. Adv Forensic Haemogenet 1996;6:192-194

  8. 8

    Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-126
    CrossRef | Web of Science | Medline

  9. 9

    Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 1991;19:3753-3753
    Web of Science | Medline

  10. 10

    Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 1991;19:195-195
    CrossRef | Web of Science | Medline

  11. 11

    Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeat polymorphism at the human beta-actin related pseudogene H-beta-Ac-psi-2 (ACTBP2). Nucleic Acids Res 1992;20:1432-1432
    CrossRef | Web of Science | Medline

  12. 12

    Marsh SGE, Bodmer JG. HLA class II nucleotide sequences, 1992. Tissue Antigens 1992;40:229-243
    CrossRef | Web of Science | Medline

  13. 13

    Bein G, Glaser R, Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 1992;39:68-73
    CrossRef | Web of Science | Medline

  14. 14

    Boon T. Toward a genetic analysis of tumor rejection antigens. Adv Cancer Res 1992;58:177-210
    CrossRef | Web of Science | Medline

  15. 15

    Moller P, Hammerling GJ. The role of surface HLA-A,B,C molecules in tumor immunity. Cancer Surv 1992;13:101-127
    Medline

  16. 16

    Schreiber H. Tumor immunology. In: Paul WE, ed. Fundamental immunology. 3rd ed. New York: Raven Press, 1993:1143-78.

  17. 17

    Colonna M. Natural killer cell receptors specific for MHC class I molecules. Curr Opin Immunol 1996;8:101-107
    CrossRef | Web of Science | Medline

  18. 18

    Goodenow RS, Vogel JM, Linsk RL. Histocompatibility antigens on murine tumors. Science 1985;230:777-783
    CrossRef | Web of Science | Medline

  19. 19

    Tanaka K, Yoshioka T, Bieberich C, Jay G. Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Annu Rev Immunol 1988;6:359-380
    CrossRef | Web of Science | Medline

  20. 20

    Ljunggren HG, Karre K. In search of the `missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244
    CrossRef | Medline

  21. 21

    Travers PJ, Arklie JL, Trowsdale J, Patillo RA, Bodmer WF. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. In: Greenwald P, ed. Research frontiers in aging and cancer: international symposium for the 1980's. NCI monograph 60. Washington, D.C.: Government Printing Office, 1982:175-80. (NIH publication no. 82-2436).

  22. 22

    Rammensee HG, Fischer Lindhal K. Less scholasticism, more exact immunology. Curr Opin Immunol 1996;8:49-50
    CrossRef | Web of Science | Medline

  23. 23

    Suthanthiran M. Transmembrane signaling requirements of T-cells: implications for regulation of alloimmunity. Transplant Proc 1995;27:Suppl 1:5-7
    Web of Science | Medline

  24. 24

    Boussiotis VA, Gribben JG, Freeman GJ, Nadler LM. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr Opin Immunol 1994;6:797-807
    CrossRef | Web of Science | Medline

  25. 25

    McHugh RS, Ahmed SN, Wang YC, Sell KW, Selvaraj P. Construction, purification and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). Proc Natl Acad Sci U S A 1995;92:8059-8063
    CrossRef | Web of Science | Medline

Citing Articles (19)

Citing Articles

  1. 1

    Stênio de Cássio Zequi, Gustavo Cardoso Guimarães, Francisco Paulo da Fonseca, Ubirajara Ferreira, Wagner Eduardo de Matheus, Leonardo Oliveira Reis, Giuliano Amorim Aita, Sidney Glina, Victor Silvestre Soares Fanni, Marjo Denisson Cardenuto Perez, Luiz Renato Montez Guidoni, Valdemar Ortiz, Lucas Nogueira, Luis Carlos de Almeida Rocha, Gustavo Cuck, Walter Henriques da Costa, Ravendra Ryan Moniz, José Hipólito Dantas Jr., Fernando Augusto Soares, Ademar Lopes. (2011) Sex with Animals (SWA): Behavioral Characteristics and Possible Association with Penile Cancer. A Multicenter Study. The Journal of Sexual Medicineno-no
    CrossRef

  2. 2

    Daniele Focosi, Monica De Donno, Serena Barbuti, Sara Davini, Silvia Fornaciari, Michele Curcio, Maria Luciana Mariotti, Fabrizio Scatena. (2011) Cancer transmissibility across HLA barriers between immunocompetent individuals: Rare but not impossible. Human Immunology 72:1, 1-4
    CrossRef

  3. 3

    Federica Sotgia, Ubaldo E Martinez-Outschoorn, Stephanos Pavlides, Anthony Howell, Richard G Pestell, Michael P Lisanti. (2011) Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Research 13:4, 213
    CrossRef

  4. 4

    S. Scott Lollis, Pablo A. Valdes, Zhongze Li, Perry A. Ball, David W. Roberts. (2010) Cause-specific mortality among neurosurgeons. Journal of Neurosurgery 113:3, 474-478
    CrossRef

  5. 5

    Hung Yang, June Lee, Clive R. Seed, Anthony J. Keller. (2010) Can Blood Tranfusion Transmit Cancer? A Literature Review. Transfusion Medicine Reviews 24:3, 235-243
    CrossRef

  6. 6

    Susan C. Lester. 2010. Safety Precautions. , 196-203.
    CrossRef

  7. 7

    E P Murchison. (2008) Clonally transmissible cancers in dogs and Tasmanian devils. Oncogene 27, S19-S30
    CrossRef

  8. 8

    Gustaf Edgren, Henrik Hjalgrim, Marie Reilly, Trung Nam Tran, Klaus Rostgaard, Agneta Shanwell, Kjell Titlestad, Johanna Adami, Agneta Wikman, Casper Jersild, Gloria Gridley, Louise Wideroff, Olof Nyrén, Mads Melbye. (2007) Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. The Lancet 369:9574, 1724-1730
    CrossRef

  9. 9

    David Dingli, Martin A. Nowak. (2006) Cancer biology: Infectious tumour cells. Nature 443:7107, 35-36
    CrossRef

  10. 10

    F. Pink, R. M. Warwick, J. Purkis, J. Pearson. (2006) Donor Exclusion in the National Blood Service Tissue Services Living Bone Donor Programme. Cell and Tissue Banking 7:1, 11-21
    CrossRef

  11. 11

    Lilian Stärck, Christian Scholz, Thomas Blankenstein, Bernd Dörken, Peter T. Daniel. (2005) Necrotic death but not irradiation abolishes costimulation of T-cell effector functions and survival by CD80-expressing tumor cells. International Journal of Cancer 116:1, 78-86
    CrossRef

  12. 12

    Toshihisa Matsumura, Michihiko Takesue, Karen A. Westerman, Teru Okitsu, Masakiyo Sakaguchi, Takuya Fukazawa, Toshinori Totsugawa, Hirofumi Noguchi, Shinichiro Yamamoto, Donna B. Stolz, Noriaki Tanaka, Philippe Leboulch, Naoya Kobayashi. (2004) ESTABLISHMENT OF AN IMMORTALIZED HUMAN-LIVER ENDOTHELIAL CELL LINE WITH SV40T AND hTERT. Transplantation 77:9, 1357-1365
    CrossRef

  13. 13

    Jakub Tolar, Joseph P. Neglia. (2003) Transplacental and Other Routes of Cancer Transmission Between Individuals. Journal of Pediatric Hematology/Oncology 25:6, 430-434
    CrossRef

  14. 14

    Takamasa Watanabe, Norikuni Shibata, Karen A. Westerman, Teru Okitsu, Jean E. Allain, Masakiyo Sakaguchi, Toshinori Totsugawa, Masanobu Maruyama, Toshihisa Matsumura, Hirofumi Noguchi, Shinichiro Yamamoto, Masaki Hikida, Akira Ohmori, Michael Reth, Anne Weber, Noriaki Tanaka, Philippe Leboulch, Naoya Kobayashi. (2003) Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers1. Transplantation 75:11, 1873-1880
    CrossRef

  15. 15

    Hirofumi Noguchi, Naoya Kobayashi, Karen A. Westerman, Masakiyo Sakaguchi, Teru Okitsu, Toshinori Totsugawa, Takamasa Watanabe, Toshihisa Matsumura, Toshiyoshi Fujiwara, Tadayoshi Ueda, Masahiro Miyazaki, Noriaki Tanaka, Philippe Leboulch. (2002) Controlled Expansion of Human Endothelial Cell Populations by Cre- loxP -Based Reversible Immortalization. Human Gene Therapy 13:2, 321-334
    CrossRef

  16. 16

    Ronald G. Strauss. (2002) Rationale for medical director acceptance or rejection of allogeneic plateletpheresis donors with underlying medical disorders. Journal of Clinical Apheresis 17:3, 111-117
    CrossRef

  17. 17

    Naoya Kobayashi, Masahiro Miyazaki, Karen A. Westerman, Hirofumi Noguchi, Masakiyo Sakaguchi, Toshinori Totsugawa, Takamasa Watanabe, Toshihisa Matsumura, Toshiyoshi Fujiwara, Philippe Leboulch, Noriaki Tanaka, Masayoshi Namba. (2001) Construction of a Differentiated Human Hepatocyte Cell Line Expressing the Herpes Simplex Virus-Thymidine Kinase Gene. ASAIO Journal 47:5, 476-480
    CrossRef

  18. 18

    Sara O. Vargas, Marie E. Cannon, Richard J. Benjamin, Janina A. Longtine. (1999) Transfusion with blood from a donor with chronic myelogenous leukemia: persistence of the bcr/abl translocation in the recipient. Transfusion 39:4, 387-391
    CrossRef

  19. 19

    Stephen P. Schiffer. (1997) Animal welfare and colony management in cancer research. Breast Cancer Research and Treatment 46:2-3, 313-331
    CrossRef